Efficacy and safety of combined neprilysin and RAS inhibition in heart failure: A meta-analysis of randomized controlled trials.

Affiliation

Department of Cardiology, Qingdao Municipal Hospital, Qingdao, Shandong 266011, China. Electronic address: [Email]

Abstract

Concerns about safety make physicians reluctant to prescribe neprilysin-renin-angiotensin system (RAS) inhibitors. This meta-analysis was performed to assess the efficacy and safety of combined neprilysin and RAS inhibition in heart failure.

Keywords

Efficacy,Meta-analysis,Neprilysin-RAS inhibition,RAS inhibition,Safety,